Combs Andrew's Form 4 filing
Prelude Therapeutics Inc (PRLD) · filed Dec 15, 2021
- Accession no.
- 0001209191-21-069796
- Filed
- Dec 15, 2021
- Trade date
- Dec 13-14, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $94.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Combs AndrewCIK 0001825005 | Officer (EVP, Head of Chemistry) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | Common Stock | PPurchaseAcquired | +4,000 | $12.12 | +$48,480 | 264,380 | Direct | |
| Dec 14, 2021 | Common Stock | PPurchaseAcquired | +4,000 | $11.60 | +$46,400 | 268,380 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.